Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Apnimed
Over the past year LXRX returned −27.0% and APMD returned −42.6%; their daily moves had a correlation of 0.17.
LXRX −27.0% APMD −42.6%Growth of $1, one year, split-adjusted
| Metric | LXRX | APMD |
|---|---|---|
| Price | $1.46 | $15.06 |
| Market cap | $649.6M | $627.0M |
| Today | +1.39% | −2.21% |
| 1 month | −16.1% | −30.8% |
| 6 months | −11.5% | — |
| Year to date | +27.0% | — |
| 1 year | +5.8% | — |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 15.7× | — |
| Net cash | $139.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | — |
| Short % of float | 11.8% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).